Physician profile
Jay Berger
NPI 1861456204
$2,186.69
in general payments reported to CMS, 2019-2025
22 companies · $309 in 2025
The $309 reported for 2025 was more than what 85% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $270 · 2021: $409 · 2022: $457 · 2023: $223 · 2024: $225 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $756.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $473.94 | 2019-2025 | |
| Sanofi Pasteur INC. | $199.96 | 2020-2024 | |
| Glaxosmithkline, LLC. | $195.43 | 2019-2025 | Bexsero, Penmenvy |
| Merck Sharp & Dohme LLC | $191.45 | 2019-2022 | |
| Kaleo, INC. | $166.20 | 2019-2024 | Auvi-Q |
| Takeda Pharmaceuticals U.S.A., INC. | $131.76 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2023 | Dupixent |
| Astrazeneca Pharmaceuticals Lp | $105.91 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $83.47 | 2025 | |
| Cognoa, INC. | $83.47 | 2021-2022 | |
| Ars Pharmaceuticals Operations, INC. | $81.85 | 2025 | Neffy |
| Covis Pharma Gmbh | $61.72 | 2021 | |
| Cranial Technologies, INC | $58.51 | 2020-2022 | |
| Aytu Biopharma, INC. | $46.49 | 2020-2022 | |
| Phadia US INC. | $35.65 | 2020-2024 | Immunocap |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $32.24 | 2022 | |
| Supernus Pharmaceuticals, INC. | $25.14 | 2021-2022 | |
| Abbvie INC. | $23.36 | 2020 | |
| Oxford Immunotec USA INC | $19.40 | 2021 | |
| Genentech USA, INC. | $17.88 | 2020 | |
| Alk-Abello, INC | $15.01 | 2021 | |
| Neos Therapeutics, Lp | $12.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.